The GWPCARE CANNABIDIOL IN RESISTANT EPILEPSY brand, founded in 2014 (United Kingdom), from 21 sister brands and 17477 competing brands. GWPCARE CANNABIDIOL IN RESISTANT EPILEPSY is owned by GW PHARMACEUTICALS, listed on the stock exchange of London Its International Securities Identification Number (ISIN) is GB0030544687. GWPCARE CANNABIDIOL IN RESISTANT EPILEPSY is part of the Drug Manufacturers activity sector.

GWPCARE CANNABIDIOL IN RESISTANT EPILEPSY is a brand of GW PHARMACEUTICALS () Share price

International deposit : 2014 Business sector Drug Manufacturers

Share price and profitability of the share GW PHARMACEUTICALS (GWPCARE CANNABIDIOL IN RESISTANT EPILEPSY)

Buy GW PHARMACEUTICALS share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Stock market history GW PHARMACEUTICALS (GWPCARE CANNABIDIOL IN RESISTANT EPILEPSY)

*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances

Other brands
GW PHARMACEUTICALS

See more brands of GW PHARMACEUTICALS

Rival brands
GWPCARE CANNABIDIOL IN RESISTANT EPILEPSY

POINT BIOPHARMA
POINT BIOPHARMA
Icosavax
Icosavax
OGX
OGX
MAUI MOISTURE
MAUI MOISTURE
POLYSPORIN
POLYSPORIN
LACTAID
LACTAID
OTHER RIVAL BRANDS

Top Popularity Web

See the full ranking
Desirable brands > Pricing Power > 5 major sectors
Desirable brands > Pricing Power > 5 major sectors

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more
MORE NEWS